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Abstract One determinant that could play a role in the
quaternary structure of human arginase is the pair of salt links
between the strictly conserved residues R255 from one monomer
and E256 from every adjacent subunit. In this work, the ionic
interaction between monomers was disrupted by expressing a
human arginase where Glu-256 had been substituted by Gln.
Biochemical analyses of the mutant protein showed that: (i) it
shares the wild-type kinetic parameters of the arginine substrate;
(ii) E256Q arginase behaves as a monomer by gel filtration; (iii)
it is drastically inactivated by dialysis in the presence of EDTA,
an inhibitory effect which is reversed by addition of Mn2+;
and (iv) the mutant enzyme loses thermal stability. The lack
of oligomerisation for E256Q arginase and the conservation
of E256 throughout evolution of the protein family suggest
that this residue is involved in the quaternary structure of
arginases. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction.
Arginase (L-arginine amidinohydrolase, EC 3.5.3.1) is a bi-
nuclear manganese metalloenzyme that catalyses the hydroly-
sis of L-arginine to L-ornithine and urea [1,2]. The biological
importance of arginase is related to its role in the control of
cellular levels of arginine and ornithine, since these amino
acids are required for various critical metabolic processes,
including protein synthesis, L-proline biosynthesis [2] and pro-
duction of polyamines [3] and nitric oxide [4^6].
The enzyme is widely distributed throughout the evolution-
ary spectrum in organisms as diverse as bacteria, fungi, plants
and animals. Two isoenzymes of arginase are found in mam-
mals, which di¡er in tissue distribution and physiological
function. Isoenzyme I is mainly localised in the liver, whilst
isoenzyme II is extrahepatic [7].
The crystal structure of rat arginase I reveals a homotri-
meric protein with a binuclear manganese cluster located at
the bottom of a 15 Aî deep active site cleft in each monomer
[8]. This structure led to the proposal of a mechanism of hy-
drolysis in which a metal-activated water molecule initiates
the nucleophilic attack on the guanidinium carbon of arginine
[8,9].
All arginases are oligomeric proteins, trimers are found in
eukaryotes, whereas prokaryotic enzymes are mainly hexame-
ric [7]. Rat arginase I has an unusual S-shaped motif in the
last 19 amino acids (residues 304^323) of the C-terminal end,
which shares the majority of inter-monomer contacts, and
thus, it was proposed as the oligomerisation determinant of
the protein. In fact, a salt link between R308 and D204 from
adjacent monomers was predicted from the 3D structure [8],
and a recent report showed that a monomeric rat arginase
results from a single mutation of R308 [10]. Moreover, dele-
tion of the last 14 residues of human arginase I produced a
mutant enzyme that was still trimeric [11], with R308 as the
C-terminus of the protein, reinforcing the role of this struc-
tural determinant for oligomerisation of mammalian arginases
[11]. Nevertheless, this picture is complicated by the fact that
most non-mammalian arginases lack this residue [12], includ-
ing a member of the protein family from the eubacterium
Bacillus caldovelux, which is an oligomeric enzyme organised
as a dimer of trimers [13].
In this work, we conducted a search for evolutionarily con-
served residues with the potential of being involved in ionic
bonds among subunits of human arginase I. A salt link at the
trimer interface has been identi¢ed between R255 and E256,
and its role in oligomerisation has been analysed by express-
ing a mutant arginase upon site-directed substitution of E256
by Q, which resulted in an active and monomeric enzyme.
2. Materials and methods
2.1. Plasmid construction and site-directed mutagenesis
All DNA manipulations were carried out using standard procedures
[14]. The full-length cDNA of human arginase I [11] was inserted into
the pBS(KS) vector (Stratagene) as a BspHI/BamHI fragment.
The mutant E256Q was obtained by inverse PCR [15] using pBlue-
script II KS containing the cDNA of human arginase I as template,
and oligonucleotides GLUP1: 5P-cAgGGTCTCTACATCACAGAA-
GAA-3P and GLUP2: 5P-CCTGTATGTCAGACCTCCCAC-3P (low-
er-case letters are the bases altered to introduce the desired mutation,
and the underlined base introduces a silent mutation to avoid internal
hybridisations). Before ligation, the PCR product was phosphorylated
with polynucleotide kinase, treated with Pfu polymerase in order to
obtain ¢lled-in fragments, and digested with DpnI to eliminate the
template. The enzyme used in the inverse PCR was Elongase enzyme
mix (Gibco BRL). After ligation, plasmids containing coding sequen-
ces for wild-type (WT) and E256Q arginases were transformed in
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Escherichia coli XLI-blue (Stratagene), double-digested with BspHI/
BamHI and ligated into pET 11d (Clontech), which were transformed
in E. coli BL21 (Clontech). The full lengths of both WT and E256Q
arginases were veri¢ed by sequencing.
2.2. Human arginase I and E256Q mutant production and puri¢cation
Expression of the WT and E256Q arginases from the pET vector
and preparation of soluble protein extracts from transformed bacteria
were the same as described previously for the expression from the
Fig. 1. Determinants for quaternary structure of arginase. A: Sequence alignment and comparison of arginase I from Rattus norvegicus (RnAR-
GI; SwissProt ID: P07824), Homo sapiens (HsARGI; P05089), Xenopus laevis (XlARGI; P30759), Saccharomyces cerevisiae (ScARGI;
P00812), Bacillus caldovelox (BcARGI; P53608) and Arabidopsis thaliana (AtARGI; P46637). Secondary structure for rat arginase I was deter-
mined by 3D model ([8] ; PDB ID: 1RLA), and secondary structure elements are indicated above their amino acid sequences (K-helices,
R[3.10]-helices, L-strands, T-turns), including the so-called S-shaped motif. Identity between both mammalian sequences, or among all arginases,
is represented by black boxes, whilst residue similarity and global frame similarity are indicated by bold characters and grey boxes, respectively.
Putative critical determinants for quaternary structure are indicated by inverted triangles (black, conserved; white, non-conserved). B: Predicted
structure of the central core of trimeric human arginase I, as deduced by homology-based 3D modelling, using the atomic co-ordinates from
the rat enzyme (1RLA), and the sequence alignment shown in A.
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pKK 223-3 vector [11] with minor modi¢cations; 1 mM of IPTG was
used in the induction during 4 h at 37‡C.
Puri¢cation of WT and E256Q arginases was performed by two
heating steps exploiting the heat stability of this protein [16]. Soluble
protein extracts were heated at 50‡C for 20 min. After cooling at 4‡C
for 10 min, the sample was heated again at 65‡C for 20 min, cooled
and centrifuged at 11 000Ug for 10 min at 4‡C. At this point, the
supernatant contains arginase at more than 90% homogeneity as esti-
mated by Coomassie blue staining of SDS^PAGE [11].
2.3. Bioinformatic tools for protein analysis
Homology modelling was performed using program facilities at the
EXpert Protein Analysis SYstem proteomics server (EXPASY; http://
www.expasy.ch) of the Swiss Institute of Bioinformatics (SIB). Espript
v1.9. and SwissModel v3.6 were used for sequence alignment and
homology-based 3D modelling, respectively [17].
2.4. Other protein analysis
Protein concentration was determined by the method of Bradford
[18].
Arginase activity was performed as indicated by Schimke [19] in a
reaction bu¡er containing 0.5 M arginine^NaOH (pH 9.7) and 1 mM
MnCl2. Mn2 was removed from WT and E256Q arginases by dial-
ysing twice against 500 volumes of bu¡er 10 mM Tris^HCl (pH 8),
150 mM NaCl and 1 mM EDTA for 2 h at 4‡C each time. Then, the
dialysed protein was used for activity assays or thermal stability stud-
ies. When the recovery of arginase activity by Mn2 or its inhibition
by Ca2 were measured, these ions were included in the reaction bu¡-
er at the desired concentrations.
Molecular mass calculations for WT and E256Q arginases were
performed by gel ¢ltration through Sephacryl S-300HR in a bu¡er
containing 25 mM Tris^HCl (pH 7.5), 1 mM MnCl2 and 150 mM
KCl [11]. The following standards were used for calibration: alcohol
dehydrogenase (150 kDa), bovine serum albumin (67 kDa), ovalbu-
min (43 kDa) and chymotrypsinogen A (25 kDa).
For thermal stability studies, puri¢ed arginase was diluted at 0.2 Wg/
Wl in 10 mM Tris^HCl (pH 7), 150 mM NaCl and 5 mM MnCl2, and
was heated at the desired temperature in a thermocycler for 20 min.
After cooling for 10 min at 4‡C, the sample was centrifuged at
11 000Ug for 10 min at 4‡C. Supernatant containing the soluble pro-
tein was used for arginase activity. Tm was calculated as the temper-
ature at which the e¡ect was half maximal.
3. Results
3.1. Sequence alignments and homology modelling
The predicted structure of the central core of human argi-
nase I (Fig. 1B) reveals a network of cross-salt links involving
residues D204, R255, E256 and R308 from every monomer. A
direct role in oligomerisation has been demonstrated for the
D204^R308 ionic bond [10], which is conserved in mammalian
and amphibian arginases (Fig. 1A). Beside that, a second ionic
interaction involves R255 and E256 from every adjacent
monomer, and since R255 and E256 are strictly conserved
in all oligomeric arginases, including Glu for Asp substitution
in a plant enzyme, these observations suggest that E256^R255
salt links could play a role in all oligomeric arginases.
3.2. Kinetic parameters and oligomerisation state
A single replacement of E256 by Q was performed by site-
directed mutagenesis in the coding sequence for human argi-
nase I (see Section 2).
Native and mutant E256Q arginases were evaluated for
catalytic properties. Under standard conditions and saturating
Mn2 concentration (1 mM), puri¢ed samples of WT and
E256Q arginases showed very similar speci¢c activities (536
and 561 U/mg, respectively). In addition, Km and kcat of both
WT and mutant enzymes did not di¡er signi¢cantly, with Km
26 and 22 mM, and kcat 447 and 467 s31, respectively. These
results indicate that E256Q retains the WT catalytic proper-
ties.
The oligomerisation state of WT and E256Q arginases was
analysed by gel ¢ltration chromatography through Sephacryl
S-300HR. Fig. 2 shows the calibration for determination of
apparent molecular mass and Kav for WT and mutant forms
of human arginase I. The molecular masses obtained for both
proteins were 102 and 34 kDa, respectively, which correlate
well with trimeric and monomeric 35-kDa polypeptide sub-
units [11]. The elution pro¢les for both proteins (results not
shown) revealed only one peak, without shoulders, indicating
the lack of additional oligomerisation (secondary) forms. This
result suggests that the E256Q mutation abolishes interactions
among subunits, indicating that the predicted salt link R255^
E256 from adjacent monomers is an important determinant
for the trimeric state of human arginase. In addition, since the
E256Q monomeric protein was active, a situation also found
for the R308 mutants expressed from rat arginase [10], it
might be concluded that trimerisation is not critical for argi-
nase activity.
3.3. Inhibition by EDTA and activation by Mn2+
When human arginase I was dialysed in the presence of
EDTA, a 50% of inhibition of enzyme activity was observed
Fig. 2. Molecular mass determination by size exclusion chromatog-
raphy. Standard proteins (F) are indicated in Section 2. Other sym-
bols: WT arginase (a) and E256Q mutant (O).
Fig. 3. E¡ect of EDTA on arginase activity and reversion by Mn2.
Open bars correspond to WT arginase and hatched bars correspond
to mutant E256Q.
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(Fig. 3). In contrast, dialysis of E256Q arginase in the pres-
ence of EDTA produced a full inactivation of the mutant
enzyme. Both inhibitory e¡ects seem to be mediated by the
loss of Mn2 from the proteins, since metal addition restored
almost all arginase activity of WT (89%) and about 50% of
E256Q activity (Fig. 3). Moreover, the recovery by Mn2 of
E256Q arginase activity was inhibited by other divalent cati-
ons, Mg2 (results not shown), and notably by Ca2, which
produced a concentration-dependent decrease of enzyme ac-
tivity, an e¡ect that was not observed for WT protein (Fig. 3).
Taken together, these results suggest that Mn2 binds revers-
ibly to human arginase I. Complete inactivation by dialysis of
E256Q arginase and inhibition by Ca2 on Mn2 activation of
the mutant enzyme indicate that it might bind Mn2 with a
lower a⁄nity than WT protein.
3.4. Thermal stability
As previously reported, WT arginase is relatively thermo-
stable [22], with a Tm of about 78‡C estimated by its relative
solubility in heated samples (Fig. 4A). However, E256Q argi-
nase was less stable, with a Tm of about 71‡C, a result which
is consistent with the loss of thermal stability of monomeric
rat arginase obtained by R308 mutation [10]. Moreover, the
activity of native arginase increases by heating to over 55‡C in
the presence of Mn2 (Fig. 4A), an e¡ect that was explained
previously by the occupation with Mn2 of site A, the lowest-
a⁄nity binding site for the metal [20,21]. The monomeric mu-
tant lacks this e¡ect (Fig. 4A), suggesting a di¡erent behav-
iour of E256Q against Mn2. In fact, dialysis in the presence
of EDTA drastically reduced the thermal stability of E256Q
arginase, whilst native arginase remained stable at 70‡C (Fig.
4B). These results also support that E256Q mutant could bind
Mn2 with a lower a⁄nity than WT protein, a behaviour
which is similar to rat arginase proteins in which active site
His were speci¢cally mutated, an alteration of the binding site
for the catalytic Mn2 that produced an inactive enzyme with
a reduced thermal stability [22].
4. Discussion
The structure of rat arginase suggested a role in oligomer-
isation of the S-shaped motif at the carboxy-end of the pro-
tein [8]. Among the several interactions localised in that re-
gion, a cross-salt link between R308 and D204 is the main
determinant for quaternary structure of rat arginase, since
point mutations in that residue produce monomeric proteins
[10], and a deletion mutant that harbours R308 at the car-
boxy-end remains trimeric [11]. Upon further investigation of
the trimer interface, a number of inter-monomer salt links
were identi¢ed that involved residues conserved in all argi-
nases. One such residue was E256 (Fig. 1). In this work we
demonstrate, by gel ¢ltration studies, that point mutation of
this residue produces an active monomer. This result indicates
the important role of E256 and its inter-monomer salt link
with R255, an interaction that stabilises the quaternary struc-
ture of human arginase. Thus, this contribution and a pre-
vious work [10] provide biochemical evidence to show the
involvement of R308 (D204) and E256 (R255) as structural
determinants for oligomerisation of mammalian arginases.
E256 and R255, but not R308 and D204, are also present in
other oligomeric arginases (Fig. 1A), and in another related
protein, agmatine ureohydrolase from E. coli [12], where the
glutamic residue is substituted by an aspartic residue (D173^
R174). Strict conservation of these amino acids among re-
motely related members of the protein family reinforces their
role as structural determinants for enzyme function.
At saturating Mn2 concentration (1 mM), E256Q arginase
is fully active, with catalytic constants similar to WT; how-
ever, the mutant protein is almost totally inactivated by dial-
ysis with 1 mM EDTA whilst WT was 50% inhibited (Fig. 3).
Considering that treatment of arginase crystal with metal che-
lators resulted in the dissociation of one Mn2 [16], and that
two Mn2/subunit are required for activity of arginase, since
the mononuclear sites are inactive [22], the inhibition of
E256Q arginase by EDTA could be interpreted as a loss of
Mn2 a⁄nity in the mutant protein. This possibility is rein-
forced by the observed inhibition of E256Q activity with other
divalent cations, such as Ca2 (Fig. 3), and by the lowering of
the thermal stability of the E256Q mutant when it is dialysed
with EDTA (Fig. 4B), a behaviour also observed in rat argi-
nase mutants in which Mn2 binding centres were mutated
(H101N or H126N) [22]. In this regard, Lavulo et al. [10]
Fig. 4. Thermal stability of WT and mutant E256Q arginases. A:
Arginase activity of soluble protein after heating for 20 min at the
indicated temperatures. B: Arginase activity of dialysed arginases
after heating for 20 min at the indicated temperatures. The activity
was performed in a reaction bu¡er containing 1 mM MnCl2. Sym-
bols: WT arginase (b) and E256Q mutant (a). Maximal activity
(100%) was the activity of WT arginase after heating at 65‡C.
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have shown that one monomeric arginase (R308K) retains
only 1 Mn2/subunit, a result that could re£ect a lower a⁄n-
ity of the mutant protein to Mn2. Interestingly, also R308K
rat arginase loss thermal stability [10], a behaviour which
correlates with the biochemical properties described for
monomeric protein from human arginase I (Fig. 4). These
and previous results [10] show the involvement of E256 and
R308 in maintaining the trimeric state of mammalian argi-
nases, and suggest that quaternary structure could play a
role in thermal stability and a⁄nity to Mn2 of arginases.
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